Where does Srini Akkaraju work?

Srini Akkaraju is Founder & Managing Partner at Samsara BioCapital and Director, Founder at Tentarix and Board director at Chinook Therapeutics U.S and Board director at A2 Biotherapeutics.

What check size does Srini Akkaraju write?

Srini Akkaraju typically writes checks of $10M – $100M.

What boards does Srini Akkaraju sit on?

Srini Akkaraju holds tracked board seats at A2 Biotherapeutics, aTYR PHARMA, Chinook Therapeutics U.S.

What companies has Srini Akkaraju invested in?

Investments tracked here include PsiThera.

Where did Srini Akkaraju go to school?

Srini Akkaraju studied at Stanford University (MD, PhD); Stanford University School of Medicine (MD, PhD); Rice University (BA, Biochemistry; Computer Science).

Srini Akkaraju

Investor

Founder & Managing Partner at Samsara BioCapital · Director, Founder at Tentarix · Board director at Chinook Therapeutics U.S · Board director at A2 Biotherapeutics

Burlingame, California

Writes $10M – $100M checks · typically $25M

Find your path to Srini

977 people in our graph can introduce you to Srini.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jennifer James to introduce you to Srini

You →Jennifer · together at Sofinnova Ventures (2013–2015) →Srini

Ask Jamie Chen to introduce you to Srini

You →Jamie · 5 people · together at Sofinnova Ventures →Srini

Ask Sam Okafor to introduce you to Srini

You →Sam · 2 people · together at Genentech →Srini

Your email: the people you already email who know Srini
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Srini
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Founder and Managing General Partner of Samsara BioCapital, holding an MD and PhD in Immunology from Stanford. He previously was a General Partner at Sofinnova Ventures, Managing Director at New Leaf Venture Partners and Panorama Capital, and a Partner at J.P. Morgan Partners, and served in business development at Genentech.

Contact· self-published, not guessed

srini@samsaracap.com

Director, Founder at Tentarix

Intro paths

→

In turn, Srini can intro founders to Tentarix's investors below.

Tentarix's investors · 3

Gilead SciencesFoster City · since 2023 Samsara BioCapitalMenlo Park · since 2023 Versant VenturesSan Francisco · $250K – $5M checks · since 2023

Board director at Chinook Therapeutics U.S

Intro paths

→

In turn, Srini can intro founders to Chinook Therapeutics U.S's investors below.

Chinook Therapeutics U.S's investors · 2

Samsara BioCapitalMenlo Park · since 2019 Versant VenturesSan Francisco · $250K – $5M checks · since 2019

Board director at A2 Biotherapeutics

Intro paths

→

In turn, Srini can intro founders to A2 Biotherapeutics's investors below.

A2 Biotherapeutics's investors · 4

Nextech InvestZurich · $648K – $3.2M checks Samsara BioCapitalMenlo Park · since 2020 The Column GroupSan Francisco · $30M checks · since 2020 Vida VenturesLos Angeles · since 2022

Co-founders at A2 Biotherapeutics

C. Alexander KambDirector

Experience

Samsara BioCapitalManaging General Partnercurrent2017 — present
Sofinnova VenturesGeneral Partner2013 — 2016Menlo Park
New Leaf Venture PartnersManaging Director2009 — 2013
Panorama CapitalManaging Director2006 — 2008
JPMPAssociate, Principal, Partner2001 — 2006
GenentechManager, BD1998 — 2001
GentenchBusiness Development1998 — 2001

Deals · 3

A2 BiotherapeuticsBoard seat

via Samsara BioCapital · filed Oct 2020 · $71.5M raise

Chinook Therapeutics U.SBoard seat

via Samsara BioCapital · filed Aug 2019 · $65M raise

aTYR PHARMABoard seat

via Samsara BioCapital · filed Sep 2017 · $45.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

PsiThera

Sources: SEC Form D filings · curated public sources.

Leave your own feedback

Colleagues at Samsara BioCapital

Abe Bassan

Principal at Samsara BioCapital

Aditya Asokan

Senior Associate at Samsara BioCapital

Alan Eisenberg

Venture Partner at Samsara BioCapital

Andrew Walker

Assistant Controller at Samsara BioCapital

Betsy Santos

Venture Partner, Chief People Officer at Samsara BioCapital

Carolyn Nguyen

Deputy General Counsel at Samsara BioCapital

Clara Dong

Senior Associate at Samsara BioCapital

Connie Su

Senior Fund Accountant at Samsara BioCapital

Network2

Christina Isacson

Partner at Lightstone Ventures

Dayton Thorpe

Angel

Investors connected to Srini in public investor directories — a warm-intro map.

Frequently asked questions

Who is Srini Akkaraju?: Founder and Managing General Partner of Samsara BioCapital, holding an MD and PhD in Immunology from Stanford. He previously was a General Partner at Sofinnova Ventures, Managing Director at New Leaf Venture Partners and Panorama Capital, and a Partner at J.P. Morgan Partners, and served in business development at Genentech.
Where does Srini Akkaraju work?: Srini Akkaraju is Founder & Managing Partner at Samsara BioCapital and Director, Founder at Tentarix and Board director at Chinook Therapeutics U.S and Board director at A2 Biotherapeutics.
What check size does Srini Akkaraju write?: Srini Akkaraju typically writes checks of $10M – $100M.
What boards does Srini Akkaraju sit on?: Srini Akkaraju holds tracked board seats at A2 Biotherapeutics, aTYR PHARMA, Chinook Therapeutics U.S.
What companies has Srini Akkaraju invested in?: Investments tracked here include PsiThera.
Where did Srini Akkaraju go to school?: Srini Akkaraju studied at Stanford University (MD, PhD); Stanford University School of Medicine (MD, PhD); Rice University (BA, Biochemistry; Computer Science).